Thymosin Alpha-1 is a 28-residue peptide, N-terminally acetylated, originally isolated from thymosin fraction 5 and corresponding to the N-terminus of prothymosin alpha.
It is used in vitro in Toll-like receptor signaling assays, cell-surface marker profiling by flow cytometry and cytokine expression studies in cultured immune cell lines.
Specifications
- Structure: 28 residues, N-terminally acetylated
- Molecular weight: 3108.3 g/mol
- Quantity: 10mg per vial
- Form: lyophilized powder
- Purity: 99.8% (HPLC)
- Endotoxin (LAL): ≤0.05 EU/mL, pass (COA 251669E)
- Lot: Black Cap · COA 251669, MDx BioAnalytical, reported 14 Nov 2025 (see COAs tab)
Storage: Store lyophilized material at −20 °C, protected from light and moisture.
For in vitro laboratory research use only. Not for human or veterinary use. Not a drug, food, cosmetic, or dietary supplement. Not for diagnostic or therapeutic use.
For in vitro laboratory research use only. Not for human or veterinary use. Not a drug, food, cosmetic, or dietary supplement. Not for diagnostic or therapeutic use.
For in vitro laboratory research use only. Not for human or veterinary use. Not a drug, food, cosmetic, or dietary supplement. Not for diagnostic or therapeutic use.
COAs:
Thymosin Alpha-1 10mg – COA251669 QC251728
Thymosin Alpha-1 10mg – Endotoxin
Each batch is supported by third-party analytical verification to ensure identity, purity, and consistency.